Stephen Kilmer | Investor Relations |
Horst Zerbe | Chief Executive Officer |
André Godin | President and Chief Financial Officer |
Dana Matzen | Vice President-Business and Corporate Development |
Frank Pietrantonio | Director of Clinical Research |
Tommy Kenny | Vice President-Intellectual Property, Legal Affairs and General Counsel |
Good morning ladies and gentlemen. And welcome to the IntelGenx’s Third Quarter 2022 Financial Results Call. At this time all participants are in a listen-only mode and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Stephen Kilmer, Investor Relations. Sir, the floor is yours.